Treats angina pectoris due to coronary artery disease. Sold as Ismo, Monoket, Imdur. Every FDA application for this active ingredient: 3 branded and 20 generic.
As of Nov 16, 2026, FDA lists 23 applications for Isosorbide Mononitrate (sold as Ismo, Monoket, Imdur), first approved Dec 30, 1991, with 0 new uses approved and 0 published complete response letters.
| Isosorbide Mononitrate ER | Part D | $61.9M | +3% | 1,140,146 |
| Isosorbide Mononitrate | Part D | $4.5M | +65% | 15,129 |
| Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's PhenomenonSystemic Sclerosis (SSc), Raynaud Disease Secondary to Scleroderma · Khon Kaen University | Phase 3 | Not yet recruiting | Aug 12, 2026 |
| Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine TherapyMalignant Digestive System Neoplasm · Mayo Clinic | Phase 1 / Phase 2 | Recruiting | Mar 9, 2026 |
| Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)Stroke, Lacunar, Stroke, Acute Ischemic · Beijing Tiantan Hospital | Phase 3 | Not yet recruiting | Nov 26, 2025 |
| Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled TrialCervical Ripening · Raid M. Al-Ani | Not applicable | Active, not recruiting | Aug 13, 2025 |
| Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's DiseaseMeniere´s Disease · Lunan Better Pharmaceutical Co., LTD. | Phase 2 / Phase 3 | Not yet recruiting | Jan 9, 2025 |
| The FOCUS-ADHF RegistryAcute Heart Failure With Reduced Ejection Fraction, Decompensation; Heart, Congestive · ASL Città di Torino | — | Recruiting | Dec 10, 2024 |
| Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel DiseasesStroke, Ischemic, Small Vessel Cerebrovascular Disease · The First Affiliated Hospital with Nanjing Medical University | — | Recruiting | Dec 4, 2024 |
| Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsHeart Failure, Congestive · Heart Center Research, LLC | Phase 4 | Recruiting | Jan 23, 2024 |
| Dec 30, 1991 | IsmoNDA 19091 · New molecular entity | Promius Pharma | 7 | Discontinued |
| Jun 30, 1993 | MonoketNDA 20215 · New formulation or manufacturer | Omnivium Pharms | 14 | Marketed |
| Aug 12, 1993 | ImdurNDA 20225 · New dosage form | Schering Plough | 8 | Discontinued |
| Sep 22, 1998 | Isosorbide MononitrateANDA 75041 | Alkermes Gainesville | 2 | Discontinued |
| Oct 30, 1998 | Isosorbide MononitrateANDA 75037 | Genus | 3 | Marketed |
| Oct 30, 1998 | Isosorbide MononitrateANDA 75155 | Chartwell Molecular | 19 | Marketed |
| Nov 27, 1998 | Isosorbide MononitrateANDA 75147 | Ani Pharms | 3 | Marketed |
| Dec 31, 1998 | Isosorbide MononitrateANDA 75306 | Actavis Elizabeth | 4 | Discontinued |
| Oct 7, 1999 | Isosorbide MononitrateANDA 75166 | Skyepharma AG | 1 | Discontinued |
| Mar 16, 2000 | Isosorbide MononitrateANDA 75395 | Zydus Hlthcare | 10 | Marketed |
| Apr 17, 2000 | Isosorbide MononitrateANDA 75522 | Dexcel Ltd | 12 | Marketed |
| Jun 19, 2000 | Isosorbide MononitrateANDA 75448 | Ivax Sub Teva Pharms | 11 | Discontinued |
| Oct 5, 2000 | Isosorbide MononitrateANDA 75361 | Hikma | 0 | Discontinued |
| Jan 7, 2005 | Isosorbide MononitrateANDA 76813 | Hikma | 3 | Discontinued |
| Aug 11, 2010 | Isosorbide MononitrateANDA 90598 | Strides Pharma Intl | 0 | Discontinued |
| Jun 3, 2011 | Isosorbide MononitrateANDA 200270 | Torrent Pharms | 0 | Marketed |
| Jun 3, 2011 | Isosorbide MononitrateANDA 200495 | Torrent Pharms | 0 | Marketed |
| Oct 24, 2017 | Isosorbide MononitrateANDA 209684 | Accord Hlthcare | 0 | Discontinued |
| Aug 29, 2018 | Isosorbide MononitrateANDA 210822 | Dexcel Ltd | 1 | Marketed |
| Nov 5, 2018 | Isosorbide MononitrateANDA 210918 | Riconpharma LLC | 0 | Marketed |
| Apr 29, 2022 | Isosorbide MononitrateANDA 214115 | Shandong | 0 | Marketed |
| Nov 7, 2022 | Isosorbide MononitrateANDA 216557 | Aurobindo Pharma | 0 | Marketed |
| Feb 15, 2024 | Isosorbide MononitrateANDA 218255 | Zydus Pharms | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA